We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) Diltiazem hydrochloride extended release 360mg capsule, USP (Ingenus Pharmaceuticals , LLC)
Section 19A approved medicine
(Approval lapsed) Diltiazem hydrochloride extended release 360mg capsule, USP (Ingenus Pharmaceuticals , LLC)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
DILTIAZEM SANDOZ CD diltiazem hydrochloride 360mg capsule bottle (unprinted) - ARTG 131304
Indication(s)
- For the treatment of hypertension.
- For the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. Since the safety and efficacy of CD capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.
Images
